Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Journal Scan / Research · December 16, 2021

Safety and Immunogenicity of Seven COVID-19 Vaccines as a Third Dose (Booster)

The Lancet

 

Additional Info

Disclosure statements are available on the authors' profiles:

The Lancet
Safety and immunogenicity of seven COVID-19 vaccines as a third dose (Booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial
Lancet 2021 Dec 02;[EPub Ahead of Print], Alasdair P S Munro, MRCPCH

Further Reading